Psychiatric outcomes in outpatients affected by long COVID: A link between mental health and persistence of olfactory complaint.

Anosmia COVID-19 Neuroplasticity Psychiatric history Psychiatry Stress

Journal

World journal of psychiatry
ISSN: 2220-3206
Titre abrégé: World J Psychiatry
Pays: United States
ID NLM: 101610480

Informations de publication

Date de publication:
19 Apr 2024
Historique:
received: 03 12 2023
revised: 28 01 2024
accepted: 21 03 2024
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 25 4 2024
Statut: epublish

Résumé

Anosmia was one of the main symptoms of coronavirus disease 2019 (COVID-19). A psychiatric history ( To compare the rate of psychiatric disorder among post-COVID patients without anosmia We conducted a prospective case control study from March 2020 to May 2021. Patients recruited at the ENT department of Nice University Hospital had a subjective olfactory complaint (visual analogue scale) for over 6 wk and a molecular or CT-proven severe acute respiratory syndrome coronavirus 2 diagnosis confirmed by serology. Post-COVID patients without persistent olfactory disorders were recruited at the university hospital infectiology department. Psychiatric medical histories were collected by a psychiatrist during the assessments. Thirty-four patients with post-COVID-19 olfactory complaints were included in the first group of the study. Fifty percent of the patients were female ( The presence of a psychiatric history may constitute a potential risk factor for the development of long COVID due to persistent anosmia. It therefore seems important to establish reinforced health monitoring after a COVID 19 infection in at-risk patients. Further prospective, translational, and collaborative studies are needed to extrapolate these results to the general population.

Sections du résumé

BACKGROUND BACKGROUND
Anosmia was one of the main symptoms of coronavirus disease 2019 (COVID-19). A psychiatric history (
AIM OBJECTIVE
To compare the rate of psychiatric disorder among post-COVID patients without anosmia
METHODS METHODS
We conducted a prospective case control study from March 2020 to May 2021. Patients recruited at the ENT department of Nice University Hospital had a subjective olfactory complaint (visual analogue scale) for over 6 wk and a molecular or CT-proven severe acute respiratory syndrome coronavirus 2 diagnosis confirmed by serology. Post-COVID patients without persistent olfactory disorders were recruited at the university hospital infectiology department. Psychiatric medical histories were collected by a psychiatrist during the assessments.
RESULTS RESULTS
Thirty-four patients with post-COVID-19 olfactory complaints were included in the first group of the study. Fifty percent of the patients were female (
CONCLUSION CONCLUSIONS
The presence of a psychiatric history may constitute a potential risk factor for the development of long COVID due to persistent anosmia. It therefore seems important to establish reinforced health monitoring after a COVID 19 infection in at-risk patients. Further prospective, translational, and collaborative studies are needed to extrapolate these results to the general population.

Identifiants

pubmed: 38659602
doi: 10.5498/wjp.v14.i4.507
pmc: PMC11036454
doi:

Types de publication

Journal Article

Langues

eng

Pagination

507-512

Informations de copyright

©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: Authors declare no conflict of interest.

Auteurs

Victoria Metelkina-Fernandez (V)

Department of Psychiatry, Nice University Hospital, Nice 06000, France.

Louise-Emilie Dumas (LE)

Department of Child and Adolescent Psychiatry, Université Côte d'Azur, Nice 06200, France.

Clair Vandersteen (C)

ENT, Head and Neck Institute, Nice 06100, France.

David Chirio (D)

Department of Infectiology, Nice University Hospital, Nice 06200, France.

Auriane Gros (A)

Department of Orthophony, Université Côte d'Azur, Nice 06100, France.

Arnaud Fernandez (A)

Department of Child and Adolescent Psychiatry, Université Côte d'Azur, Nice 06200, France.
Cobtek, Université Côte d'Azur, Nice 06100, France. arnaud.fernandez@hpu.lenval.com.

Florence Askenazy (F)

Department of Child and Adolescent Psychiatry, Université Côte d'Azur, Nice 06200, France.

Valeria Manera (V)

Cobtek, Université Côte d'Azur, Nice 06100, France.

Classifications MeSH